Extraordinary clinical response to ibrutinib in low-grade ovarian cancer guided by organoid drug testingHeidi J. Gray, Carla Grandori, Hallie A. Swan et al.|npj Precision Oncology|2023Cited by 26
Complete Remission of Widely Metastatic Human Epidermal Growth Factor Receptor 2–Amplified Pancreatic Adenocarcinoma After Precision Immune and Targeted Therapy With Description of Sequencing and Organoid CorrelatesDaniel A. King, Calvin J. Kuo, Amber R. Smith et al.|JCO Precision Oncology|2023Cited by 15
Complete remission in a patient with widely metastatic HER2-amplified pancreatic adenocarcinoma following multimodal therapy informed by tumor sequencing and organoid profilingDaniel A. King, Calvin J. Kuo, Amber R. Smith et al.|medRxiv|2021Cited by 1